Ally Bridge Group »

Karyopharm Therapeutics shares owned by Ally Bridge Group

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Ally Bridge Group from 13F filings

Historical chart of Ally Bridge Group investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Ally Bridge Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Ally Bridge Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.4M 250k 5.57

More positions owned by Ally Bridge Group

Soleno Therapeutics (SLNO)
Praxis Precision Medicines I Com New (PRAX)
Minerva Neurosciences Com New (NERV)
Ovid Therapeutics (OVID)
Compass Pathways Sponsored Ads (CMPS)
Tarsus Pharmaceuticals (TARS)
Solid Biosciences Com New (SLDB)
Compass Therapeutics Call Option (CMPX)
Promis Neurosciences Com Shs (PMN)
Edgewise Therapeutics (EWTX)
Uniqure Nv SHS Call Option (QURE)
Eupraxia Pharmaceuticals (EPRX)
Cytomx Therapeutics (CTMX)
Inventiva Sa Ads (IVA)
Perspective Therapeutics Com New (CATX)

View all positions for Ally Bridge Group

Top funds holding Karyopharm Therapeutics

Ikarian Capital
Commodore Capital
RA Capital Management
T. Rowe Price Investment Management
Goldman Sachs Group
Catalio Capital Management
Affinity Asset Advisors
Susquehanna International
Boothbay Fund Management
Squadron Capital Management
Vanguard Capital Management
Jane Street
Vanguard Group
Millennium Management
Citadel Advisors

View all funds holding Karyopharm Therapeutics